FDA grants accelerated approval for first plasmid DNA-based immunotherapy for adults
The U.S. Food and Drug Administration granted accelerated approval for Voceryq to treat adults with recurrent respiratory papillomatosis.
The U.S. Food and Drug Administration granted accelerated approval for Voceryq to treat adults with recurrent respiratory papillomatosis.
NASA and the National Institutes of Health announced the QuSAFE Challenge to advance quantum-enabled sensing for in vitro testing.